Day: February 6, 2026

Tel Aviv, Israel, Feb. 06, 2026 (GLOBE NEWSWIRE) — Jeffs’ Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace expanding into the global homeland security sector through advanced artificial intelligence (“AI”) -driven solutions, today announced that its wholly-owned subsidiary, KeepZone AI Inc. (“KeepZone”), has entered into an exclusive reseller agreement (the “Agreement”) with DSIT Solutions Ltd. (“DSIT”), a global leader in underwater domain awareness and acoustic intelligence solutions. KeepZone will help lead DSIT’s entry into the Mexican market to counter underwater drug smuggling and protect offshore assets, as part of DSIT’s strategic effort to support national authorities and critical infrastructure operators. Drug trafficking...

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) — Cambridge Acquisition Corp. (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company and led by our Chairman, Michael Cam- Phung, Chief Executive Officer, Brent Michael Cox and Chief Financial Officer, Anthony Michael Naimo, today announced the pricing of its initial public offering of 20,000,000 units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant will entitle the holder thereof to purchase one Class A ordinary share at $11.50 per share. The units are expected to trade on the Global Market tier of the Nasdaq Stock Market (“Nasdaq”) under the ticker symbol “CAQUU” beginning February 6, 2026. No fractional warrants will be...

CAMBRIDGE, Mass., Feb. 06, 2026 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on February 1, 2026, it awarded inducement grants to six new employees under Intellia’s 2024 Inducement Plan as a material inducement to employment. The inducement grants consisted of time-based restricted stock units (“RSUs”) for an aggregate of 30,600 shares of Intellia’s common stock, with one-third of such RSUs vesting annually over three years. All equity vesting is subject to each employee’s continued service as an employee of, or other service provider to, Intellia through the applicable vesting dates. All of the above-described awards were granted outside of Intellia’s stockholder-approved equity...

A new heart pizza available February 9–15Papa Johns Canada – Pizza My HeartPizza My Heart is a one-topping heart pizza on thin crust, made with Papa Johns’ signature fresh, never frozen dough, vine-ripened tomato sauce, and real mozzarella cheese.EDMONTON, Alberta, Feb. 06, 2026 (GLOBE NEWSWIRE) — Papa Johns Canada is launching Pizza My Heart, a new limited-time heart pizza available nationwide for Valentine’s Day. On menus from February 9 through February 15, Pizza My Heart is a one-topping heart pizza on thin crust, made with Papa Johns’ signature fresh, never frozen dough, vine-ripened tomato sauce, and real mozzarella cheese. Priced at $17.99, the limited-time offering gives customers a festive way to mark Valentine’s Day at home. Whether it’s a date night in, a family dinner, or something in between, Pizza...

MONTVALE, N.J., Feb. 06, 2026 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, February 20, 2026, at 11:00 AM Eastern Time (ET) to review fourth quarter and full year 2025 results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will host the call. Fourth quarter and full year 2025 results will be published prior to the market opening on Friday, February 20, 2026. The press release, and its accompanying financial exhibits, will also be available on the Company website, www.balchem.com, prior to the conference call. Institutional investors, analysts and other members of the financial community are invited to join the live call by dialing 800-715-9871 (toll free USA/Canada), +1-646-307-1963 (USA/International) or 647-932-3411 (Canada/Toronto),...